ClinicalTrials.gg
RecruitingNCT07383688Updated Oct 14, 2026

Neuspera Revision Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics

An observational study in Urinary Urge Incontinence, sponsored by Neuspera Medical, Inc.. Recruiting at 1 site in United States. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Neuspera Medical, Inc. · Observational

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.
Updated Oct 14, 2026Now RecruitingFirst site in United States+6 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
22 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 135 studies in Urinary Incontinence, Urge with a site in United States — 19 open to participants now, 26 under way, none of them phase 3. Urinary Incontinence, Urge · United States.

Planned enrollment
6th of 15
100 · median 47
Started
2026
with 4 others
Observational
15 of 135
4 open now
Primary completion
2027-04
later than 18 of 25 live
Registered
133rd of 135
by date

Among the 135 studies in Urinary Incontinence, Urge with a site in United States, this one is the 6th largest by planned enrollment of the 15 observational ones that give a count, is one of 5 that started in 2026, is one of 15 observational ones, reaches primary completion later than 18 of the 25 other live ones, and was the 133rd registered.

Urinary Incontinence, Urge

243 studies on the registry are indexed under Urinary Incontinence, Urge; 39 are open to participants now.

Browse Urinary Incontinence, Urge studies →

Open to participants now

19 of the 135 studies in Urinary Incontinence, Urge with a site in United States are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 25 Urinary Incontinence, Urge studies recruiting now, 18 (72%) set no upper age limit and 2 (8%) stop at 75 or younger; 1 takes children under 18; 2 take healthy volunteers.

This study: 22 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 135 studies in Urinary Incontinence, Urge with a site in United States, or all of them as a file.
02

Study summary

Single-arm study where subjects' responses to a questionnaire for the traditional Sacral Neuromodulation (SNM) devices will be compared to the responses regarding the Neuspera SNM System.

Read the detailed description

Subjects will be enrolled in a single-arm study and followed for 1-month after implant of the Neuspera SNM System.

Subjects will complete a questionnaire regarding their experience with the traditional SNM system prior to the Neuspera implant, then undergo an implant of the Neuspera SNM system using standard of care according to the device's commercial labeling.

Up to 20 subjects will be enrolled.

03

Conditions studied

  • Urinary Urge Incontinence
04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Study population with 22 years of age or older and who have or have previously had a traditional SNM system.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Currently have a traditional SNM device and has decided to have the device replaced with the Neuspera SNM System OR previously had an existing traditional SNM implant that was completely removed within the last year
  2. Is 22 years of age or older
  3. Had documented at least 50% improvement in UUI episodes on a bladder diary with either a stimulation trial or with their traditional system
  4. Is a good surgical candidate and qualified to receive the Neuspera SNM System per the device labeling
  5. Is capable of participating in all testing and follow-up clinic visits associated with this clinical study.

Exclusion criteria

Exclusion Criteria:

  1. Has a for the Neuspera SNM System per the device labeling.
  2. Has plans to enroll or is currently enrolled in another device or drug trial during his/her participation in this study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Neuspera Replacement Cohort

    Subjects with previous traditional SNM system and now undergoing implant of the Neuspera SNM System

    Device: Neuspera Implantable Sacral Neuromodulation System

Interventions

  • DeviceNeuspera Implantable Sacral Neuromodulation System

    Stimulation of the Sacral Nerve

06

What researchers measure

Primary outcomes

  1. Subject Questionnaire

    The changes to subject questionnaire responses for the Neuspera SNM system compared to responses regarding traditional SNM systems.

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
08

References and documents

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Apr 2027, 12 months after the start.

Of 19 observational studies under Urinary Incontinence, Urge, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 45. This study's planned 12 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 14, 2026: start Mar 2026 → Apr 2026, primary completion Oct 2026 → Apr 2027 and completion Oct 2026 → Apr 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 26, 2026
First posted
Feb 3, 2026
StartActual
Apr 1, 2026was Mar 2026
Primary completionEst.
Apr 2027was Oct 2026
CompletionEst.
Apr 2027was Oct 2026
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 14, 2026
Sites
1 site added — first site in United States
Show site
  • Specialty Clinical Research of St. Louis · St Louis, United States
Oct 14, 2026
Start date
Mar 2026→Apr 1, 2026 (actual)
Oct 14, 2026
Primary completion
Oct 2026→Apr 2027
Oct 14, 2026
Study completion
Oct 2026→Apr 2027
Oct 14, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Primary Study measureNow Subject QuestionnaireTime frame: 1 month
Oct 14, 2026
Title
FREEDOMNeuspera Revision Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United States
    Show site
    • Specialty Clinical Research of St. Louis · St Louis, United States
    Start date Mar 2026→Apr 1, 2026 (now actual)
    Primary completion Oct 2026→Apr 2027
    Study completion Oct 2026→Apr 2027
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Primary Study measureNow Subject QuestionnaireTime frame: 1 month
    Title FREEDOMNeuspera Revision Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07383688
Lead sponsor
Neuspera Medical, Inc.
Responsible party
Sponsor
First posted
Feb 3, 2026
Start date
Apr 1, 2026
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Oct 14, 2026

Study contacts

Mark Vollmer
Contact
mark.vollmer@neuspera.com
408-433-3839
Shital Patel
Contact
shital.patel@neuspera.com
3235281320
Kellen Choi, DO
principal investigator · University of Louisville Health System

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion